Contact
Mail: jens.buciek@regionh.dk
Phone: +45 42 60 90 86
Jens' research focuses on diabetic neuropathy, testing new treatments to prevent progression and improving management of this severe complication.
Research area
- Diabetic sensimotor neuropathy
- Diabetic autonomic neuropathy
Current projects
Mineralocorticoid receptor antagonist treatment for diabetic cardiovascular autonomic neuropathy: FibroCAN study a double-blind, randomized, placebo-controlled trial. The aim of this trial is to evaluate the efficacy of Finerenone in reducing the progression of early-stage cardiovascular autonomic neuropathy (CAN) and other neuropathies in individuals with type 2 diabetes.